« Charles River ends acquisition bid - The Boston Globe | Main | Seattle Genetics lands $900M deal with Genentech »

08/03/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f2ccfc94970b

Listed below are links to weblogs that reference Xconomy Readers Set $20B Pricetag on Genzyme;Is That Too Rich for Sanofi-Aventis?:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada